Last update 01 Nov 2024
Shanghai MabLab Biotechnology Co., Ltd.
Private Company|
2012|
Shanghai Shi, China
Last update 01 Nov 2024
Overview
Tags
Endocrinology and Metabolic Disease
Skin and Musculoskeletal Diseases
Other Diseases
Monoclonal antibody
Biosimilar
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项随机、双盲、平行对照，比较生产场地变更后的 CMAB807注射液与普罗力®在中国成年男性健康受试者中单次给药的药代动力学、药效学、安全性和免疫原性的 I 期比对研究
[Translation] A randomized, double-blind, parallel-controlled Phase I study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of CMAB807 injection after a change of manufacturing site with Prolix® in healthy adult male subjects in China
一项随机、双盲、平行对照，比较CMAB807注射液与Prolia治疗中国高骨折风险的绝经后女性骨质疏松症的临床有效性、安全性和免疫原性的III期比对研究
[Translation] A randomized, double-blind, parallel-controlled Phase III study comparing the clinical efficacy, safety, and immunogenicity of CMAB807 injection with Prolia in the treatment of osteoporosis in postmenopausal women at high risk of fracture in China
随机、双盲、平行对照，比较CMAB807与Prolia在中国成年男性健康受试者中单次给药的I期比对研究
[Translation] A randomized, double-blind, parallel-controlled, Phase I study comparing CMAB807 with Prolia as a single dose in healthy Chinese adult male subjects
100 Clinical Results associated with Shanghai MabLab Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai MabLab Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai MabLab Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 27 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free